Record Information |
---|
Version | 2.0 |
---|
Created at | 2022-09-12 01:36:53 UTC |
---|
Updated at | 2022-09-12 01:36:53 UTC |
---|
NP-MRD ID | NP0322692 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 2-[(2-{[2-(3-amino-2-hydroxy-n-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid |
---|
Description | 2-[(2-{[2-(3-Amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. It was first documented in 2002 (PMID: 31593387). Based on a literature review a significant number of articles have been published on 2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid (PMID: 27253005) (PMID: 27583328) (PMID: 36127157) (PMID: 36127156). |
---|
Structure | CCCCCCCC(N)C(O)C(=O)N(C)C(CC[S+](C)[O-])C(O)=NC(CC1=CC=C(O)C=C1)C(O)=NC(CC1=CC=C(OC)C=C1)C(O)=O InChI=1S/C35H52N4O9S/c1-5-6-7-8-9-10-27(36)31(41)34(44)39(2)30(19-20-49(4)47)33(43)37-28(21-23-11-15-25(40)16-12-23)32(42)38-29(35(45)46)22-24-13-17-26(48-3)18-14-24/h11-18,27-31,40-41H,5-10,19-22,36H2,1-4H3,(H,37,43)(H,38,42)(H,45,46) |
---|
Synonyms | Value | Source |
---|
2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoate | Generator | 2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulphinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoate | Generator | 2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulphinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid | Generator |
|
---|
Chemical Formula | C35H52N4O9S |
---|
Average Mass | 704.8800 Da |
---|
Monoisotopic Mass | 704.34550 Da |
---|
IUPAC Name | 2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid |
---|
Traditional Name | 2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCCCC(N)C(O)C(=O)N(C)C(CC[S+](C)[O-])C(O)=NC(CC1=CC=C(O)C=C1)C(O)=NC(CC1=CC=C(OC)C=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C35H52N4O9S/c1-5-6-7-8-9-10-27(36)31(41)34(44)39(2)30(19-20-49(4)47)33(43)37-28(21-23-11-15-25(40)16-12-23)32(42)38-29(35(45)46)22-24-13-17-26(48-3)18-14-24/h11-18,27-31,40-41H,5-10,19-22,36H2,1-4H3,(H,37,43)(H,38,42)(H,45,46) |
---|
InChI Key | IQSISHQRPPTNJD-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Peptidomimetics |
---|
Sub Class | Hybrid peptides |
---|
Direct Parent | Hybrid peptides |
---|
Alternative Parents | |
---|
Substituents | - Hybrid peptide
- Tyrosine or derivatives
- Phenylalanine or derivatives
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Alpha-amino acid amide
- 3-phenylpropanoic-acid
- Beta amino acid or derivatives
- Amphetamine or derivatives
- Alpha-amino acid or derivatives
- N-substituted-alpha-amino acid
- Phenoxy compound
- Methoxybenzene
- Phenol ether
- Anisole
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Alkyl aryl ether
- Fatty acyl
- Benzenoid
- N-acyl-amine
- Monosaccharide
- Fatty amide
- Monocyclic benzene moiety
- Tertiary carboxylic acid amide
- Amino acid
- Sulfoxide
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Amino acid or derivatives
- Sulfinyl compound
- Monocarboxylic acid or derivatives
- Ether
- Carboxylic acid
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Amine
- Alcohol
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Authors unspecified: Childhood Vascular Tumors Treatment (PDQ(R)): Patient Version. 2002. [PubMed:27253005 ]
- Authors unspecified: Childhood Esophageal Cancer Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:31593387 ]
- Authors unspecified: Financial Toxicity and Cancer Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:27583328 ]
- Gadot R, Najera R, Hirani S, Anand A, Storch E, Goodman WK, Shofty B, Sheth SA: Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022 Sep 20. pii: jnnp-2021-328738. doi: 10.1136/jnnp-2021-328738. [PubMed:36127157 ]
- Koggel LM, Lantinga MA, Buchner FL, Drenth JPH, Frankema JS, Heeregrave EJ, Heringa M, Numans ME, Siersema PD: Predictors for inappropriate proton pump inhibitor use: observational study in primary care. Br J Gen Pract. 2022 Jun 24. pii: BJGP.2022.0178. doi: 10.3399/BJGP.2022.0178. [PubMed:36127156 ]
- LOTUS database [Link]
|
---|